# Ontario Institute for Regenerative Medicine

Ontario Institute for Regenerative Medicine is a Foundation based in Toronto, Canada.

## Overview

- **Organization type:** Foundation
- **Headquarters:** Toronto, Canada
- **Region:** North America
- **Address:** Toronto, ON, Canada
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** oirm.ca
- **LinkedIn:** https://www.linkedin.com/company/ontario-institute-for-regenerative-medicine

## Regulatory record

- **Reports private funds:** No

## About

The Ontario Institute for Regenerative Medicine is a non-profit organization based in Toronto, Canada. Founded in 2014, it focuses on stem-cell research and accelerating regenerative medicine through accelerator programs and investments. OIRM made its first investment in Inspire Biotherapeutics in a Pre-Seed round on March 15, 2023.

## Sectors

- Digital Health
- Healthcare Services

## Offices

- Montreal, QC, Canada

## Questions

### How does OIRM differ from a standard research-grant foundation?

OIRM operates as a translational network rather than a reactive grant-maker. It assembles disease-specific teams — each spanning academic investigators, clinicians, and industry partners — and funds them against milestones tied to clinical adoption. The model originated with Ontario's 2011 health-research strategy and means the institute actively manages project portfolios rather than simply disbursing and monitoring.

### What therapeutic areas does OIRM fund?

The institute's main disease-team programs cover cardiac regeneration, neural repair and neurodegeneration, diabetes — with an emphasis on cell-replacement strategies — musculoskeletal disorders, and ocular disease. Project selection reflects Ontario's population disease burden and the province's existing academic strengths in stem-cell biology.

### Does OIRM take equity in the spinouts it funds?

OIRM does not hold equity positions. Commercialization and intellectual-property management are handled by partner organizations, primarily the Centre for Commercialization of Regenerative Medicine (CCRM). OIRM's funding creates the translational data that de-risks those assets for CCRM, which then structures spinout vehicles and licenses.

### Who are OIRM's core institutional partners?

Disease-team investigators are drawn from the University Health Network, the Ottawa Hospital Research Institute, McMaster University, the University of Toronto, and several other Ontario research hospitals. Industry matching often comes through CCRM's consortium, which includes large-cap biopharma and cell-therapy manufacturing firms.

### How is OIRM funded, and does its capital pool renew?

The institute launched with a commitment from the Government of Ontario's Ministry of Colleges and Universities, supplemented by federal tri-council grants and industry matching. Funding is renewed on a multi-year cycle tied to Ontario's research-innovation budgets; the most recent disease-team cycle was announced in 2023. Exact dollar figures are not published as a consolidated endowment or fund size.

## Related profiles

- [Centre C3i](https://altss.com/profile/centre-c3i)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ontario-institute-for-regenerative-medicine

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology